Prognostic significance of the TEL-AML1 fusion gene in pediatric acute lymphoblastic leukemia in Turkey

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 3, 2003, Pages 204-208

  Ozbek, Ugur ^a,e   Sirma, Sema ^a   Agaoglu, Leyla ^a   Yuksel, Lebriz ^b   Anak, Sema ^a   Yildiz, Inci ^b   Devecioglu, Omer ^a   Timur, Cetin ^c   Meral, Adalet ^d   Gedikoglu, Gunduz ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c SSK Goztepe Hospital   (Turkey)

^d ULUDAG UNIVERSITY   (Turkey)

^e Deneysel Tip Arastirma Enstitusu   (Turkey)

Author keywords

Acute lymphoblastic leukemia; Pediatric leukemia; TEL AML1

Indexed keywords

HYBRID PROTEIN; TEL AML1 PROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER INCIDENCE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; FEMALE; FUSION GENE; HUMAN; IMMUNOPHENOTYPING; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; RECIPROCAL CHROMOSOME TRANSLOCATION; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TURKEY (REPUBLIC);

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FEMALE; HUMANS; IMMUNOPHENOTYPING; INFANT; INFANT, NEWBORN; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; ONCOGENE PROTEINS, FUSION; PROGNOSIS; SURVIVAL RATE; TURKEY;

EID: 0037336142     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200303000-00005     Document Type: Article

References (25)

1. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993;81:2237-51.
2. Rubnitz JE, Downing JR, Pui CH, et al. TEL gene rearrangements in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. J Clin Oncol 1997;15:1150-7.
3. McLean TW, Ringold S, Neuberg D, et al. TEL/AML1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 1996;88:4262-8.
4. Borkhardt A, Cazzaniga G, Viehmann S, et al. Incidence and clinical relevance of TEL-AML1 fusion genes in children with (ALL) enrolled in the German and Italian multicenter therapy trials. Blood 1997;99:1-7.
5. Romana SP, Poirel H, Leconiat M, et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995;86:4252-69.
6. Shurtleff SA, Buijs A, Behm FG, et al. TEL-AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995;9:1985-9.
7. Aguiar RCT, Sohal J, Rhee FV, et al. TEL-AML1 fusion in acute lymphoblastic leukemia of adult. Br J Haematol 1996;95:673-7.
8. Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 1997;15:417-74.
9. Rubnitz JE, Behm FG, Wichlan D, et al. Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup. Leukemia 1999;13:19-21.
10. Hubeek I, Ramakers-Van Woerden NL, Pieters R, et al. TEL/AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukemia. Br J Haematol 2001;113:254-8.
11. Seeger K, Adams HP, Buchwald D, et al. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. Blood 1998; 91:1716-22.
12. Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute Imphoblastic leukemia. J Clin Oncol 1996;14:18-24.
13. Nachman JB, Sather HN, Sensel MG, et al. Augmented post induction therapy for children with high-risk acute lymphoblastic leukemia and slow response to initial therapy. N Engl J Med 1998;338:1663-71.
14. Schrappe M, Reiter A, Welte K, et al. Risk adapted treatment in childhood acute lymphoblastic leukemia: Data from the Berlin-Frankfurt-Münster Group. Haematol Blood Transfus 1997;38:601-10.
15. Chomczynsky P, Sacchi N. Single-step method of RNA isolation by acide guanidium thiocyonate-phenol chloroform extraction. Anal Biochem 1987:162-6.
16. Kusec R, Laczika K, Knöbl P, et al. AML1/ETO fusion mRNA can be detected in remission blood samples of ALL patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 1994; 8:735-9.
17. Janssen JWG, Fonatsch C, Ludwig W-D, et al. Polymerase chain reaction analysis of BCR-ABL sequences in adult Philadelphia chromosome-negative acute lymphoblastic leukemia patients. Leukemia 1992;6:463.
18. Jamil A., Theil KS, Kahwash S, et al. TEL/AML1 fusion gene: its frequency and prognostic significance in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 2000;122:73-8.
19. Pajor L, Lacza A, Jakso P, et al. Characteristics of TEL/AML-1 positive acute lymphoblastic leukemia in Hungarian children. Med Pediatr Oncol 2001;37: 409-11.
20. Zuna J, Hrusak O, Kalinova M, et al. TEL-AML1 positivity in childhood ALL: Average or better prognosis? Czech Paediatric Haematology Working Group. Leukemia 1999;13:22-4.
21. Takahashi Y, Horibe K, Kiyoi H, et al. Prognostic significance of TEL-AML1 fusion transcript in childhood B-precursor acute lymphoblastic leukemia. J Pediatr Hematol Oncol 1998;20:190-5.
22. Liang DC, Chou TB, Chen JS, et al. High incidence of TEL-AML1 in Childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia 1996; 10:991.
23. Ford AM. Fasching K, Panzer-Grümayer ER, et al. Origins of late relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes. Blood 2001;98:558-64.
24. Harbott J, Viehmann S, Borkhardt A, et al. Incidence of TEL-AML1 fusion gene analyzed consecutively in children with childhood acute lymphoblastic leukemia in relapse. Blood 1997;90:4933.
25. Loh ML, Silverman LB, Young ML, et al. Incidence of TEL-AML1 fusions in children with relapsed acute lymphoblastic leukemia. Blood 1998;92:4792-7.